Abstract
We recently developed nontoxic, broad-spectrum virucidal gold nanoparticles, less than 10nm sized, modified with sulfonic acids (mesilate) that mimic heparan sulfates.Camostat, a serine protease inhibitor can introduce gold nanoparticles to the influenza virus via ionic bonds.In this study, we examined the ability of a novel sulfonated colloid gold to inhibit the virus in vivo. Thus, camostat-colloid gold is a promising candidate for the development of antiviral drugs to prevent and treat influenza infection.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
E-mail: nanfabeltangold{at}gmail.com
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.